首页 > 最新文献

Orphanet Journal of Rare Diseases最新文献

英文 中文
Pulmonary hemorrhage as an early clue: an integrated clinical-imaging-genetic diagnostic insight for vascular Ehlers-Danlos syndrome. 肺出血作为早期的线索:对血管性埃勒斯-丹洛斯综合征的综合临床-成像-遗传诊断见解。
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-23 DOI: 10.1186/s13023-026-04327-0
Yaqi Wang, Huaiya Xie, Lan Song, Kexin Xu, Junping Fan, Ping Wang, Nan Wu, Ting Zhang, Juhong Shi, Kai-Feng Xu, Xinlun Tian, Xue Zhang
{"title":"Pulmonary hemorrhage as an early clue: an integrated clinical-imaging-genetic diagnostic insight for vascular Ehlers-Danlos syndrome.","authors":"Yaqi Wang, Huaiya Xie, Lan Song, Kexin Xu, Junping Fan, Ping Wang, Nan Wu, Ting Zhang, Juhong Shi, Kai-Feng Xu, Xinlun Tian, Xue Zhang","doi":"10.1186/s13023-026-04327-0","DOIUrl":"https://doi.org/10.1186/s13023-026-04327-0","url":null,"abstract":"","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147504511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging the gap between patient and physician perspectives on management of generalized myasthenia gravis: a Delphi consensus study. 弥合病人和医生对广泛性重症肌无力管理的观点之间的差距:德尔菲共识研究。
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-20 DOI: 10.1186/s13023-026-04312-7
Andrew Chan, Monika Kaempf, Wolfgang N Löscher, John Vissing, Johan Voerman, Eva Frostell-Pyhäjärvi, Sari Atula
{"title":"Bridging the gap between patient and physician perspectives on management of generalized myasthenia gravis: a Delphi consensus study.","authors":"Andrew Chan, Monika Kaempf, Wolfgang N Löscher, John Vissing, Johan Voerman, Eva Frostell-Pyhäjärvi, Sari Atula","doi":"10.1186/s13023-026-04312-7","DOIUrl":"https://doi.org/10.1186/s13023-026-04312-7","url":null,"abstract":"","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147491540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The landscape of 605 genetically confirmed distinct rare diseases in a single center in Mexico (2005-2025). 墨西哥单一中心605种经基因证实的独特罕见疾病的情况(2005-2025年)。
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-20 DOI: 10.1186/s13023-026-04318-1
Juan Carlos Zenteno, Vianey Ordoñez-Labastida, Luis Montes-Almanza, Froylan Garcia-Martinez, Alejandro Martinez-Herrera, David Carreño-Bolaños, Rocio Arce-Gonzalez, Oscar F Chacón-Camacho
{"title":"The landscape of 605 genetically confirmed distinct rare diseases in a single center in Mexico (2005-2025).","authors":"Juan Carlos Zenteno, Vianey Ordoñez-Labastida, Luis Montes-Almanza, Froylan Garcia-Martinez, Alejandro Martinez-Herrera, David Carreño-Bolaños, Rocio Arce-Gonzalez, Oscar F Chacón-Camacho","doi":"10.1186/s13023-026-04318-1","DOIUrl":"https://doi.org/10.1186/s13023-026-04318-1","url":null,"abstract":"","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147491576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in hereditary angioedema in the modern treatment era in China: a focus on diagnosis, treatment, and prognosis. 中国现代治疗时代遗传性血管性水肿研究进展:关注诊断、治疗和预后。
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-20 DOI: 10.1186/s13023-026-04314-5
Ye Zhao, Duowu Zou
{"title":"Advances in hereditary angioedema in the modern treatment era in China: a focus on diagnosis, treatment, and prognosis.","authors":"Ye Zhao, Duowu Zou","doi":"10.1186/s13023-026-04314-5","DOIUrl":"https://doi.org/10.1186/s13023-026-04314-5","url":null,"abstract":"","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147491522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study. pegunigalsidase alfa治疗法布里病成人患者的长期疗效和安全性:BRIGHT F51 III期开放标签扩展研究长达5年的结果
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-20 DOI: 10.1186/s13023-026-04303-8
Myrl Holida, Aleš Linhart, Nicola Longo, Eric Wallace, Camilla Tøndel, Derralynn Hughes, David G Warnock, Antonio Pisani, François Eyskens, Patrick Deegan, Ulla Feldt-Rasmussen, Ozlem Goker-Alpan, Ankit Mehta, Giovanni Piotti, Vito Fichera, Meng Wang, Raul Chertkoff, Stephen Waldek, William R Wilcox, John A Bernat
{"title":"Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study.","authors":"Myrl Holida, Aleš Linhart, Nicola Longo, Eric Wallace, Camilla Tøndel, Derralynn Hughes, David G Warnock, Antonio Pisani, François Eyskens, Patrick Deegan, Ulla Feldt-Rasmussen, Ozlem Goker-Alpan, Ankit Mehta, Giovanni Piotti, Vito Fichera, Meng Wang, Raul Chertkoff, Stephen Waldek, William R Wilcox, John A Bernat","doi":"10.1186/s13023-026-04303-8","DOIUrl":"https://doi.org/10.1186/s13023-026-04303-8","url":null,"abstract":"","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147491565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating imaging and genomics in prenatal Treacher Collins syndrome: evidence for practice and policy. 整合成像和基因组学产前Treacher Collins综合征:实践和政策的证据。
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-19 DOI: 10.1186/s13023-025-04094-4
Chunling Li, Wei Huang, Zhongzhi Gan, Yin Ling, Liyan Qiu, Yuanling Xiao, Fu Xiong, Fang Yang
{"title":"Integrating imaging and genomics in prenatal Treacher Collins syndrome: evidence for practice and policy.","authors":"Chunling Li, Wei Huang, Zhongzhi Gan, Yin Ling, Liyan Qiu, Yuanling Xiao, Fu Xiong, Fang Yang","doi":"10.1186/s13023-025-04094-4","DOIUrl":"10.1186/s13023-025-04094-4","url":null,"abstract":"","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":"21 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13001374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147486740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute hepatic porphyria masquerading as familial Mediterranean fever: results of a cross-sectional porphobilinogen screening. 急性肝卟啉症伪装成家族性地中海热:结果的横断面卟啉原筛选。
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-19 DOI: 10.1186/s13023-026-04308-3
Gulustan Musayeva, Esra İşat, Mehmet Yıldız, Mehmet Şerif Cansever, Serdal Uğurlu, Dilek Uludağ Alkaya, Sezgin Şahin, Kenan Barut, Ertuğrul Kıykım, Çiğdem Aktuğlu-Zeybek, Özgür Kasapçopur, Tanyel Zubarioglu
{"title":"Acute hepatic porphyria masquerading as familial Mediterranean fever: results of a cross-sectional porphobilinogen screening.","authors":"Gulustan Musayeva, Esra İşat, Mehmet Yıldız, Mehmet Şerif Cansever, Serdal Uğurlu, Dilek Uludağ Alkaya, Sezgin Şahin, Kenan Barut, Ertuğrul Kıykım, Çiğdem Aktuğlu-Zeybek, Özgür Kasapçopur, Tanyel Zubarioglu","doi":"10.1186/s13023-026-04308-3","DOIUrl":"https://doi.org/10.1186/s13023-026-04308-3","url":null,"abstract":"","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147486657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health-related quality of life in adults with epidermolysis bullosa: a cross-sectional study in seven European countries using EQ-5D-5L. 大疱性表皮松解症成人的健康相关生活质量:在7个欧洲国家使用EQ-5D-5L进行的横断面研究
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-19 DOI: 10.1186/s13023-026-04299-1
Renata Linertová, Márta Péntek, Benjamín Rodríguez-Díaz, Christine Bodemer, Vinzenz Hübl, May El Hachem, Gudrun Salamon, Verónica Alonso-Ferreira, Georgi Stefanov, Ritu Jain, Yolanda Ramallo-Fariña, Lidia García-Pérez

Background: Epidermolysis bullosa (EB) is a rare genetic disorder that causes extreme skin fragility, chronic pain, and functional impairment, with major psychosocial and economic consequences. Health-related quality of life (HRQoL) data is critical to capture the full burden of EB. Health utilities derived from preference-based generic instruments such as the EQ-5D-5L provide standardized health status utility values that enable cross-disease comparisons and provide input data for cost-utility analyses to inform resource allocation. There is a notable lack of multinational, up-to-date utility data for EB. This cross-sectional study aimed to assess HRQoL in adults with EB across seven European countries (Austria, Bulgaria, Germany, Hungary, Italy, France, and Spain) using the EQ-5D-5L.

Results: A total of 328 adults with EB participated in the survey, 61% were female, 37% were between 18 and 30 years old and 46% had dystrophic EB. Based on self-reported symptoms, 58% were classified as severe EB. Pain/discomfort was the most affected EQ-5D-5L dimension (92% reporting problems; 27% severe or extreme). The mean EQ-5D value (health utility) was 0.63 (SD 0.32), ranging from 0.57 in Spain to 0.71 in Bulgaria. Patients with severe EB reported significantly lower utilities than non-severe cases (0.52 vs. 0.78, p < 0.001). Mean EQ VAS score was 60 (SD 23.2). Compared to general population norms, EB patients in all countries had markedly lower HRQoL (p < 0.005), with large effect sizes for the EQ-5D value (Cohen's d ≥ 0.8). Symptomatic burden and functional deterioration were the primary drivers of HRQoL impairments.

Conclusions: This multinational study provides the most extensive and current health utility data for adults with EB in Europe. Findings reveal the profound HRQoL impairment in EB, particularly in severe cases. These standardized utility values fill a major evidence gap, supporting their use in health economic evaluations, cross-disease comparisons, and policy development.

背景:大疱性表皮松解症(EB)是一种罕见的遗传性疾病,可导致皮肤极度脆弱、慢性疼痛和功能障碍,并具有严重的社会心理和经济后果。健康相关生活质量(HRQoL)数据对于捕捉EB的全部负担至关重要。来自基于偏好的通用工具(如EQ-5D-5L)的卫生实用工具提供了标准化的健康状态实用值,可以进行跨疾病比较,并为成本效用分析提供输入数据,从而为资源分配提供信息。值得注意的是,缺乏跨国公司最新的电子商务实用数据。本横断面研究旨在使用EQ-5D-5L评估七个欧洲国家(奥地利、保加利亚、德国、匈牙利、意大利、法国和西班牙)EB成人的HRQoL。结果:328名成人EB患者参与调查,其中61%为女性,37%为18 - 30岁,46%为营养不良型EB。根据自我报告的症状,58%被归类为严重EB。疼痛/不适是EQ-5D-5L维度中受影响最大的(92%报告有问题,27%报告严重或极端)。平均EQ-5D值(健康效用)为0.63 (SD 0.32),范围从西班牙的0.57到保加利亚的0.71。重度EB患者报告的效用显著低于非重度患者(0.52 vs. 0.78, p)。结论:这项跨国研究为欧洲成人EB患者提供了最广泛和最新的健康效用数据。研究结果显示,EB患者的HRQoL严重受损,特别是在严重病例中。这些标准化的效用值填补了一个主要的证据空白,支持它们在卫生经济评估、跨疾病比较和政策制定中的使用。
{"title":"Health-related quality of life in adults with epidermolysis bullosa: a cross-sectional study in seven European countries using EQ-5D-5L.","authors":"Renata Linertová, Márta Péntek, Benjamín Rodríguez-Díaz, Christine Bodemer, Vinzenz Hübl, May El Hachem, Gudrun Salamon, Verónica Alonso-Ferreira, Georgi Stefanov, Ritu Jain, Yolanda Ramallo-Fariña, Lidia García-Pérez","doi":"10.1186/s13023-026-04299-1","DOIUrl":"https://doi.org/10.1186/s13023-026-04299-1","url":null,"abstract":"<p><strong>Background: </strong>Epidermolysis bullosa (EB) is a rare genetic disorder that causes extreme skin fragility, chronic pain, and functional impairment, with major psychosocial and economic consequences. Health-related quality of life (HRQoL) data is critical to capture the full burden of EB. Health utilities derived from preference-based generic instruments such as the EQ-5D-5L provide standardized health status utility values that enable cross-disease comparisons and provide input data for cost-utility analyses to inform resource allocation. There is a notable lack of multinational, up-to-date utility data for EB. This cross-sectional study aimed to assess HRQoL in adults with EB across seven European countries (Austria, Bulgaria, Germany, Hungary, Italy, France, and Spain) using the EQ-5D-5L.</p><p><strong>Results: </strong>A total of 328 adults with EB participated in the survey, 61% were female, 37% were between 18 and 30 years old and 46% had dystrophic EB. Based on self-reported symptoms, 58% were classified as severe EB. Pain/discomfort was the most affected EQ-5D-5L dimension (92% reporting problems; 27% severe or extreme). The mean EQ-5D value (health utility) was 0.63 (SD 0.32), ranging from 0.57 in Spain to 0.71 in Bulgaria. Patients with severe EB reported significantly lower utilities than non-severe cases (0.52 vs. 0.78, p < 0.001). Mean EQ VAS score was 60 (SD 23.2). Compared to general population norms, EB patients in all countries had markedly lower HRQoL (p < 0.005), with large effect sizes for the EQ-5D value (Cohen's d ≥ 0.8). Symptomatic burden and functional deterioration were the primary drivers of HRQoL impairments.</p><p><strong>Conclusions: </strong>This multinational study provides the most extensive and current health utility data for adults with EB in Europe. Findings reveal the profound HRQoL impairment in EB, particularly in severe cases. These standardized utility values fill a major evidence gap, supporting their use in health economic evaluations, cross-disease comparisons, and policy development.</p>","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147486610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mast cell mediators in hereditary angioedema. 遗传性血管性水肿中的肥大细胞介质。
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-14 DOI: 10.1186/s13023-026-04294-6
Hanga Réka Horváth, Noémi Andrási, Eszter Nagy, Éva Imreh, Henriette Farkas
{"title":"Mast cell mediators in hereditary angioedema.","authors":"Hanga Réka Horváth, Noémi Andrási, Eszter Nagy, Éva Imreh, Henriette Farkas","doi":"10.1186/s13023-026-04294-6","DOIUrl":"https://doi.org/10.1186/s13023-026-04294-6","url":null,"abstract":"","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147459370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet gene signatures detecting pulmonary artery stenosis in patients with pulmonary hypertension. 血小板基因标记检测肺动脉高压患者肺动脉狭窄。
IF 3.5 2区 医学 Q2 GENETICS & HEREDITY Pub Date : 2026-03-13 DOI: 10.1186/s13023-026-04307-4
Junhao Jin, Hongling Su, Zunmin Wan, Yating Zhao, Hongfan Zhao, Aiping Tang, Ya Ma, Huan Liu, Tongtong Gao, Like Ma, Aqian Wang, Bo Li, Kaiyu Jiang, Fu Zhang, Yunhe Zhang, Mei Jiang, Chenxi Zhang, Min Zhang, Yunshan Cao
{"title":"Platelet gene signatures detecting pulmonary artery stenosis in patients with pulmonary hypertension.","authors":"Junhao Jin, Hongling Su, Zunmin Wan, Yating Zhao, Hongfan Zhao, Aiping Tang, Ya Ma, Huan Liu, Tongtong Gao, Like Ma, Aqian Wang, Bo Li, Kaiyu Jiang, Fu Zhang, Yunhe Zhang, Mei Jiang, Chenxi Zhang, Min Zhang, Yunshan Cao","doi":"10.1186/s13023-026-04307-4","DOIUrl":"https://doi.org/10.1186/s13023-026-04307-4","url":null,"abstract":"","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147459319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Orphanet Journal of Rare Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1